Successful Management of Neutropenic Sepsis Is Key to Better Survival of Patients With Blood Cancer in Sri Lanka: Real-World Data From the Resource-Limited Setting.

Autor:	Hewamana S; Lanka Hospital, Colombo, Sri Lanka., Skandarajah T; National Cancer Institute, Colombo, Sri Lanka., Jayasinghe C; Department of Statistics, University of Sri Jayewardenepura, Colombo, Sri Lanka., Deshapriya S; Lanka Hospital, Colombo, Sri Lanka., Gayashan D; Lanka Hospital Diagnostics, Colombo, Sri Lanka., Peiris N; Asiri Surgical Hospital, Colombo, Sri Lanka., Harischandra M; Lanka Hospital, Colombo, Sri Lanka., Gunasena P; Lanka Hospital, Colombo, Sri Lanka., Somasundaram G; Lanka Hospital, Colombo, Sri Lanka., Srinivasan V; Lanka Hospital, Colombo, Sri Lanka., Somiah S; Lanka Hospital, Colombo, Sri Lanka., Wickramarathna C; Faculty of Medicine, University of Ruhuna, Matara, Sri Lanka., Hewawasam S; Lanka Hospital, Colombo, Sri Lanka., Balawardena J; Sir John Kotelawala Defence University, Colombo, Sri Lanka., Arseculeratne G; Lanka Hospital, Colombo, Sri Lanka., Wadanamby R; Lanka Hospital Diagnostics, Colombo, Sri Lanka., Galagoda G; Lanka Hospital Diagnostics, Colombo, Sri Lanka., Wijesiriwardana B; Lanka Hospital, Colombo, Sri Lanka.
Jazyk:	angličtina
Zdroj:	JCO global oncology [JCO Glob Oncol] 2024 Mar; Vol. 10, pp. e2300412.
DOI:	10.1200/GO.23.00412
Abstrakt:	Purpose: Sepsis is the main cause of nonrelapse mortality, and there are no published data on applicability of supportive care protocols from high-income countries such as Sri Lanka. The aim of the study was to investigate management and mortality of neutropenic episodes among Hemato-Oncology patients. Materials and Methods: Retrospective analysis of clinical characteristics, management, morbidity, and mortality of neutropenic Hemato-Oncology patients presented to the Lanka Hospital Blood Cancer Centre from January 1, 2019 to December 31, 2019 was performed. Results: A total of 169 neutropenic episodes were identified; 115 (68%) of such episodes were related to chemotherapy. Acute leukemia, lymphoproliferative disorders, and plasma cell disorders accounted for 23%, 69%, and 8% of patients, respectively. The median age of patients who had sepsis was 56 years, whereas that of those who had no sepsis was 53 years ( P = .49). The median time to neutropenia was 9 days for those in the sepsis group compared with 8 days in the group that had no sepsis (0.64). The median neutrophil count in the group that had sepsis was 0.06, whereas it was 0.69 in the group that had no sepsis ( P ≤ .05). The median time to commencement of antibiotics was 20 minutes. Conclusion: To our knowledge, this is the only documented study related to outcome and successful applicability of western supportive care protocols to Sri Lankan patients with neutropenia. In this study, we have shown that neutropenic sepsis can be successfully managed in the setting of limited resources with service development, following guidelines and staff training.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu